Gathering Momentum, Setting Sail for the Future | SinoPharm Medical Shanghai Industry Invited to Attend the Opening Ceremony of Cenop's China Headquarters

On October 29th, Synop (Suzhou) Scientific Instruments Co., Ltd. (hereinafter referred to as "Synop") held a grand opening ceremony for its China headquarters in Suzhou. Lin Hong, General Manager of Guoyao (Shanghai) Medical Device Industry Co., Ltd. (hereinafter referred to as "Shanghai Industry"), and her team were invited to attend and witness this milestone event.

In her address, Lin Hong expressed her honor in partnering with Synop. She stated that Shanghai Industry, as an integral part of Sinopharm's large health industry, leverages Sinopharm's advantages across the entire life cycle, industrial chain, and ecosystem, using its strong distribution network to share resources with Synop. Following the signing of a Memorandum of Understanding in June 2023, a strategic business agreement was reached in August of this year, signifying a new high point in the partnership. She expressed confidence in their continued collaboration to support the high-quality development of China's healthcare industry.

Lu Tao, Synop's Asia-Pacific General Manager, warmly welcomed Lin Hong and her team. He emphasized that Synop (Suzhou) Scientific Instruments Co., Ltd., since its inception, has carried the dream of innovation and market expectations, committed to developing leading products and core technologies. As a leader in small/wide-angle X-ray scattering technology, Synop, through its X-ray technology expertise, high-performance products and excellent services, provides an excellent user experience for global customers while constantly pushing for innovation in small/wide-angle X-ray scattering technology. Synop's laboratory SAXS/WAXS characterization has reached unprecedented levels. Synop is confident that these advantages will enable it to stand out in fierce market competition and lead the industry's new trends.

According to the strategic business agreement, both parties will leverage their respective advantages in leading technologies and service networks to actively promote comprehensive strategic cooperation, creating new competitive advantages and better providing users with comprehensive, professional, timely, and considerate services to promote the high-quality development of China's healthcare industry.

Source: Shanghai Industry

Original link:

https://open.work.weixin.qq.com/wwopen/mpnews?mixuin=xkoQEgAABwBARlc9AAAUAA&mfid=WW0331-GTQsyQAABwBRPH6qWXxdzQXe83U8a&idx=0&sn=704a98186763a85ea096d4c9b9f1a321&auth=1&state=